Skip to content
Abierto

Award notice, first published as justification

Relenza (Zanamivir) Rotadisk, 5MG

75A50325C00019

Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.

Awarded

Glaxosmithkline, LLC

$45,499,950.00 on the award notice, September 27, 2025, contract 75A50325C00019

Description

As published on SAM.gov.

Relenza (Zanamivir) Rotadisk, 5MG

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
FRHTPHMZMX47
CAGE
667E9
Vendor location
Durham, NC
Contract
75A50325C00019, definitive contract
Obligated
$27,299,970.00, potential $45,499,950
Actions
3 between September 26, 2025 and August 18, 2026
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Relenza (Zanamivir) Rotadisk, 5MG
Match
award number 75A50325C00019 equals the contract number; same awarding office 75A503 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 10, 2025

    Justification, originally award notice

    SAM.gov, notice 9135d307476246ad96270f0cf20e42f1

  2. October 10, 2025

    Award notice

    Awarded to GLAXOSMITHKLINE LLC Durham for $45,499,950. SAM.gov, notice d3465953897f4f21a9825df37485d75c

Points of contact